A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants
Status:
Recruiting
Trial end date:
2021-12-27
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the effect of nipocalimab on the
pharmacokinetic (PK) of etanercept (Part 1); and to assess the effect of hydroxychloroquine
(HCQ) on total serum immunoglobin G (IgG) reduction by nipocalimab (Part 2) in healthy
participants.